Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

1,296 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection

NCT01371578

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • Alabama Liver and Digestive Specialists Montgomery, Alabama, United States
  • California Liver Institute Beverly Hills, California, United States
  • Scripps Clinic La Jolla, California, United States
View all 55 locations
View Trial Details
Completed

Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection

NCT01435044

Conditions
Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +25 more
Locations
  • Alabama Liver & Digestive Specialists Montgomery, Alabama, United States
  • Bakersfield, California, United States
  • Coronado, California, United States
  • La Mesa, California, United States
View all 44 locations
View Trial Details
Completed

A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

NCT01271790

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • Alabama Liver and Digestive Specialists Montgomery, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
View all 144 locations
View Trial Details
Completed

GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus

NCT01356160

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Tucson, Arizona, United States
  • Beverly Hills, California, United States
  • Coronado, California, United States
  • Costa Mesa, California, United States
View all 23 locations
View Trial Details
Completed

A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

NCT01225380

Conditions
Blood-Borne Infections, Chronic Hepatitis C Infection, Communicable Diseases, +9 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Advanced Clinical Research Institute Anaheim, California, United States
  • Scripps Clinic La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 114 locations
View Trial Details
Completed

Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects

NCT00987337

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Pfizer Investigational Site Anaheim, California, United States
  • Pfizer Investigational Site Anaheim, California, United States
  • Pfizer Investigational Site Coronado, California, United States
  • Pfizer Investigational Site La Jolla, California, United States
View all 77 locations
View Trial Details

Related conditions